Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000361751

Medchemexpress LLC Purinostat mesylate | 2650188-32-0 | 99.45% | 586.62 | 100 MG
SDP

Catalog No. 5000361751
Encompass_Preferred

Purinostat mesylate is a selective inhibitor of HDAC, inhibiting class I and class IIb HDACs. It induces apoptosis, affects the cell cycle, and exhibits potent anti-leukemia effects in vivo, making it suitable for research on lymphoblastic leukemia.

  • Selective inhibitor of HDACs
  • Inhibits class I and class IIb HDACs (IC50s 0.81 to 11.5 nM)
  • Induces apoptosis
  • Affects cell cycle of LAMA84 and 188 BL-2 cells
  • Exhibits potent anti-leukemia effects in vivo
  • Suitable for research on lymphoblastic leukemia
  • High purity: 99.45%

Catalog No. 50-003-61751 Supplier Medchemexpress LLC Supplier No. HY150109100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Purinostat mesylate is a selective inhibitor of HDAC, inhibiting class I and class IIb HDACs. It induces apoptosis, affects the cell cycle, and exhibits potent anti-leukemia effects in vivo, making it suitable for research on lymphoblastic leukemia.

  • Selective inhibitor of HDACs
  • Inhibits class I and class IIb HDACs (IC50s 0.81 to 11.5 nM)
  • Induces apoptosis
  • Affects cell cycle of LAMA84 and 188 BL-2 cells
  • Exhibits potent anti-leukemia effects in vivo
  • Suitable for research on lymphoblastic leukemia
  • High purity: 99.45%

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.